Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1183/13993003.03002-2020 http://scihub22266oqcxt.onion/10.1183/13993003.03002-2020 33479105!7821834!33479105     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Eur+Respir+J 2021 ; 57 (2): ä Nephropedia Template TP {{tp|p=33479105|t=2021. Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection |pdf=|usr=}}{{33479105}} gab.com Text Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection JO: Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=33479105 #FOAvip About half of the patients recovering from SARS-CoV-2 have persistent symptoms and lower lung function as long as 2 months after infection. This is common even in younger SARS-CoV-2 convalescents with few comorbidities. https://bit.ly/38dyCYB Twit Text FOAVip Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection ????Eur Respir J http://www.kidney.de/pget.php?&tw=1&pmid=33479105 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33479105 #FOAvip English Wikipedia <ref>{{Cite pmid|33479105}}</ref> Residual symptoms and lower lung function in patients recovering from SARS-CoV-2 infection #MMPMID33479105 Trinkmann F; Muller M; Reif A; Kahn N; Kreuter M; Trudzinski F; Eichinger M; Heussel CP; Herth FJF Eur Respir J 2021[Feb]; 57 (2): ä PMID33479105show ga About half of the patients recovering from SARS-CoV-2 have persistent symptoms and lower lung function as long as 2 months after infection. This is common even in younger SARS-CoV-2 convalescents with few comorbidities. https://bit.ly/38dyCYB |*COVID-19 Drug Treatment[MESH] |*COVID-19/complications/physiopathology/therapy[MESH] |*Long Term Adverse Effects/diagnosis/epidemiology/etiology/physiopathology[MESH] |*Respiratory Function Tests/methods/statistics & numerical data[MESH] |*Respiratory Insufficiency/diagnosis/epidemiology/etiology/physiopathology[MESH] |Comorbidity[MESH] |Convalescence[MESH] |Female[MESH] |Germany/epidemiology[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Muscle Weakness/etiology/physiopathology[MESH] |Risk Factors[MESH] |SARS-CoV-2[MESH]Residual symptoms and lower lung function in patients recovering from (epmc).pdf DeepDyve Pubget Overpricing